Literature DB >> 20567070

Laboratory procedures for the diagnosis of tuberculosis: a survey in ten Italian Regions.

Maria Luisa Moro1, Simona Nascetti, Filomena Morsillo, Matteo Morandi.   

Abstract

The characteristics of laboratories performing tuberculosis (TB) diagnostic procedures were investigated in ten Italian Regions, through a mailed questionnaire. Three hundred and eighty laboratories answered (70.8 % response rate), 250 of which performed directly at least one TB diagnostic procedure. Standard criteria concerning microscopy, culture, identification, and drug susceptibility testing were frequently not satisfied, particularly those related to the volume of activity (32 % of laboratories performing microscopy examined 10 samples and 36 % of those performing culture performed 20 cultures per week), processing time, biosafety requirements and participation to internal/external quality control programs. The survey' results highlight the need to promote the adoption of standardized procedures and to centralize the mycobacteriology testing in a reduced number of high quality laboratories, in order to improve diagnostic accuracy, resource management and quality of surveillance data.

Entities:  

Mesh:

Year:  2010        PMID: 20567070     DOI: 10.4415/ANN_10_02_12

Source DB:  PubMed          Journal:  Ann Ist Super Sanita        ISSN: 0021-2571            Impact factor:   1.663


  2 in total

1.  External quality assessment of AFB smear microscopy performances and its associated factors in selected private health facilities in Addis Ababa, Ethiopia.

Authors:  Lemi Mosissa; Abebaw Kebede; Tedla Mindaye; Muluwork Getahun; Sisay Tulu; Kassu Desta
Journal:  Pan Afr Med J       Date:  2016-06-09

Review 2.  Immune Biomarkers for Diagnosis and Treatment Monitoring of Tuberculosis: Current Developments and Future Prospects.

Authors:  Yean K Yong; Hong Y Tan; Alireza Saeidi; Won F Wong; Ramachandran Vignesh; Vijayakumar Velu; Rajaraman Eri; Marie Larsson; Esaki M Shankar
Journal:  Front Microbiol       Date:  2019-12-18       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.